首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 125 毫秒
1.
目的 探讨表皮生长因子受体(EGFR)与核因子-kB p65(NF-kB p65)在舌鳞状细胞癌(TSCC)中的表达特征及二者间的相关性.方法 选取2002年1月至2009年12月佳木斯大学第二附属医院(口腔医院)口腔颌面外科手术切除TSCC组织标本43例;另选择来源于同期因舌部良性病变而手术切除的病变周围正常舌组织标本15例.采用免疫组化法检测组织中EGFR、NF-kB p65的表达.结果 TSCC组织中EGFR、NF-kB p65的阳性表达率分别为72.1%、67.4%.TSCC患者EGFR和NF-kB p65的表达在不同性别、年龄、病理组织分型方面差异无统计学意义(P>0.05),而在TNM分期及有无淋巴结转移方面差异有统计学意义(P<0.05).EGFR与NF-kBp65表达呈正相关关系(r=0.741,P< 0.01).结论 EGFR和NF-kB p65在TSCC组织中呈过表达,二者的联合检测可以作为判断TSCC生物学行为和指导临床治疗的指标.  相似文献   

2.
目的 检测舌鳞状细胞癌(TSCC)中microRNA-125b的表达,分析与TSCC患者临床病理特征的关系。方法 采用实时荧光定量聚合酶链反应(RT-qPCR)检测35例TSCC组织及对应的癌旁正常组织中microRNA-125b的表达情况,并分析microRNA-125b在TSCC组织中的表达与临床特征的关系。采用原位杂交技术(ISH)检测35例TSCC组织及对应的癌旁正常组织切片中microRNA-125b基因的表达水平。结果 RT-qPCR结果显示,TSCC组织和癌旁正常组织中microRNA-125b的相对表达量分别为2.32±0.69和0.87±0.32,TSCC组织中microRNA-125b的表达显著高于癌旁正常组织,差异有统计学意义(P<0.001);35例TSCC组织中microRNA-125b的表达水平与年龄、性别、病理分级和淋巴结转移无明显相关性,而与TNM分期有明显相关性,分期越高microRNA-125b的表达水平越高(P<0.05)。经过microRNA-125b探针杂交染色结果显示,35例患者的TSCC组织和癌旁正常组织的染色平均密度分别为0.010±0.003和0.004±0.001,癌组织高于癌旁组织,差异有统计学意义(P<0.05)。结论 microRNA-125b在35例TSCC患者中高表达,并与临床分期相关,提示microRNA-125b表达上调可能参与TSCC的发生发展。  相似文献   

3.
目的:研究核转录因子-κB(nuclear factor-κB,NF-κB)和环氧化酶-2(cyclooxygenase-2,COX-2)在舌鳞状细胞癌(tongue squamous cell carcinoma,TSCC)发生、发展中的作用及两者间的关系.方法:取经手术病理证实的舌鳞状细胞癌标本50例,采用SP免疫组化法检测舌鳞状细胞癌组织中NF-κB和COX-2的表达情况.应用SPSS11.0软件包,采用x2检验分析NF-κB和COX-2表达的关系及其与临床病理特征的关系.结果:低分化TSCC组织中NF-κB的阳性表达率为48%,显著高于中、高分化的癌组织(P<0.05);有淋巴结转移的TSCC组织中,NF-κB的阳性表达率为42.3%,显著高于无淋巴结转移的患者(P<0.05).低分化TSCC组织中,COX-2的阳性表达率为68.0%,显著高于中、高分化者(P<0.05);有淋巴结转移组,COX-2的阳性表达率为61.5%,高于无淋巴结转移组(P<0.05).在COX-2阴性表达的患者中,NF-κB阳性表达率为3.8%(1/26),显著低于COX-2阳性表达的患者中NF-κB阳性表达的比率(P<0.05).结论:NF-κB和COX-2在低分化及有淋巴结转移的舌鳞状细胞癌中的阳性表达率均高于中、高分化及无淋巴结转移的病例,且两者间的表达具有相关性,NF-κB和COX-2可能参与了舌鳞状细胞癌的发生与发展.  相似文献   

4.
目的探讨Bmi1在舌鳞状细胞癌(TSCC)发生、发展过程中的作用。 方法采用免疫组化法对收集的77例TSCC组织、22例舌癌前病变(白斑)以及12例正常舌组织中Bmi1表达水平进行检测。应用SPSS 17.0对数据进行处理分析。组间比较采用t检验和单因素方差分析。Bmi1的表达与TSCC患者临床病理因素间的相关性分析采用Pearson和Spearman相关检验。TSCC患者的Bmi1生存曲线分析采用Kaplan-Meier法,曲线间比较采用Log-rank检验。以P<0.05为差异有统计学意义。 结果白斑和TSCC组织中Bmi1的表达水平显著高于正常舌组织(白斑与正常舌组织对比的P= 0.014;TSCC与正常舌组织对比的P= 0.036);中、重度白斑中Bmi1的表达水平明显高于轻度白斑(P= 0.014)。颈淋巴结转移阳性的TSCC患者标本的Bmi1表达水平显著高于颈淋巴结转移阴性患者(P= 0.006);同时,晚期患者的组织标本中Bmi1的表达水平亦明显高于早期患者(P= 0.004)。TSCC组织标本中的Bmi1表达水平与患者的年龄、性别、肿瘤大小无明显相关性,但与颈淋巴结转移阳性和临床分期呈显著正相关,差异具有统计学意义(P<0.05)。同时Bmi1与SOD2和Ki67的表达水平呈正相关(P<0.05)。Bmi1高表达组的5年生存率低于Bmi1低表达组,二者之间差异具有统计学意义(P<0.001)。 结论TSCC和白斑患者的组织标本中Bmi1的表达水平增加,表明在舌恶性肿瘤发生的早期阶段已存在Bmi1的表达,并对TSCC的发生、发展和预后产生重要影响。  相似文献   

5.
目的:探讨低氧诱导因子-1α(hypoxia inducible factor-1α,HIF-1α)在舌鳞状细胞癌(tongue squamous cellcarcinoma,TSCC)中的表达及其对临床预后的影响。方法:收集舌鳞状细胞癌组织标本49例以及相应癌旁组织标本15例。免疫组织化学法检测其中HIF-1α的表达。临床随访所选病例患者情况,将随访结果与HIF-1α表达情况进行统计分析。Kaplan-Meier方法分析无病生存期(DFS)和总生存期(OS)生存曲线,Log-Rank分析临床病理学参数与HIF-1α表达之间的意义。多变量Cox回归分析临床参数和HIF-1α表达之间的相关性。结果:在49例舌鳞状细胞癌标本中有43例表达HIF-1α,表达率为87.76%;而在癌旁组织中的表达率为33.33%,差异有统计学意义(P<0.05)。HIF-1α过表达与T分级(P=0.01)、组织分化(P<0.001)和淋巴结转移(P=0.05)密切相关。同时,HIF-1α过表达、组织分化和淋巴转移均与患者5年生存率(P<0.001,P=0.008,P<0.001)和无病生存率(P=0.01,P=0.020,P<0.001)密切相关。Cox比例风险回归模型表明,HIF-1α的过表达以及淋巴转移是影响舌鳞状细胞癌的预后独立因素。结论:舌鳞状细胞癌中存在HIF-1α的表达,HIF-1α的过表达预示舌鳞癌患者的预后较差。在舌鳞癌的检测与治疗中,它可能作为一个新的靶点发挥作用。  相似文献   

6.
目的 探讨自噬相关蛋白人第10号染色体缺失的磷酸酶及张力蛋白同源基因(phosphatase and ten-sinhomology deleted on chromosome ten,PTEN)、微管相关蛋白1轻链3(microtubule-associated protein 1 light chain 3,MAP1LC3)在舌鳞状细胞癌(tongue squamous cell carcinoma,TSCC)、癌前病变及癌旁组织中的表达及相关性,探讨其与TSCC发生、发展及转移的关系.方法 采用免疫组化SP法检测46例TSCC手术标本及13例癌前病变、13例癌旁组织标本中PTEN、MAP1LC3的蛋白表达,分析其与临床病理特征间的关系.结果 PTEN(X2=9.905,P=0.007)、MAP1LC3(X2=9.577,P=0.008)在TSCC组织、癌前病变、癌旁组织中的蛋白表达差异有统计学意义.在TSCC中,PTEN蛋白的阳性表达率(34.78%)明显低于癌旁组织(69.23%,X2=4.926,P=0.026)及癌前病变组织(76.92%,X2=7.302,P=0.007);MAP1LC3蛋白的阳性表达率(28.26%)明显低于癌旁组织(61.53%,X2=4.896,P=0.027)及癌前病变组织(69.23%,X2=7.275,P=0.007),差异均有统计学意义.PTEN与MAP1LC3蛋白表达与患者年龄、性别、吸烟、饮酒、细胞分化无关(P>0.05).颈淋巴结从无转移到转移以及临床分期越晚,PTEN蛋白及MAP1LC3蛋白的阳性表达率降低,差异有统计学意义(P<0.05).PTEN和MAP1LC3两种蛋白在复发组中阳性表达率皆较低,复发组与非复发组PTEN的蛋白表达差异有统计学意义(X2=4.269,P=0.039),而复发组与非复发组MAP1LC3的蛋白表达差异尚无统计学意义(X2=0.343,P=0.453).PTEN与MAP1LC3蛋白阳性表达呈正相关.结论 自噬相关蛋白PTEN与MAP1LC3的低表达与TSCC的临床病理特征相关,对TSCC的诊断与预后有一定参考价值.  相似文献   

7.
目的 建立稳定的人舌鳞状细胞癌(TSCC)严重联合免疫缺陷(SCID)小鼠异种移植瘤模型,初步研究其组织形态学以及生物学行为.方法 将未经治疗的新鲜人TSCC标本移植于SCID小鼠腹部皮下,当肿瘤生长至10 ~ 15 mm时,取出移植瘤再次移植传代,对比研究各代移植瘤的组织学形态,原位杂交以及免疫组织化学法检测肿瘤组织的来源.结果 75%(8/12)标本成功建立起稳定移植瘤模型,最长传至第5代.组织形态学对比显示移植瘤保持了原代瘤的组织学特征和异质性;免疫组织化学证实肿瘤细胞的人源性和基质细胞的宿主源性.结论 成功建立人TSCC SCID小鼠异种移植瘤模型,较好的保持了原代肿瘤的特性.  相似文献   

8.
目的 检测舌鳞状细胞癌(tongue squamous cell carcinoma, TSCC)中EphA7的表达,分析其表达水平与TSCC患者临床病理参数及预后的相关性。方法 应用免疫组织化学方法检测54例TSCC及配对癌旁正常组织中EphA7的表达水平,结合随访数据,分析EphA7表达水平与肿瘤病理参数、总体及无瘤生存期的关系。下调SCC9细胞系EphA7的表达水平,检测肿瘤细胞的侵袭、转移能力。采用SPSS17.0软件包进行配对资料t检验和生存分析。结果 所有TSCC组织中均发现EphA7阳性表达,EphA7高表达与不伴淋巴结转移(P<0.05)、无血管浸润(P<0.05)、致密基质细胞炎症反应(P<0.01)以及女性(P<0.05)密切相关;与EphA7低表达患者相比,EphA7高表达组表现出更长的总生存期及无瘤生存期(P<0.05)。下调EphA7表达的SCC9细胞侵袭、转移能力显著增高(P<0.05)。结论 EphA7参与肿瘤恶性进程,影响患者预后,有可能作为TSCC潜在的治疗靶点。  相似文献   

9.
目的 探讨线粒体肿瘤抑制基因1(MTUS1)在舌鳞状细胞癌(TSCC)中的表达及其临床意义。方法 应用免疫组织化学检测80例TSCC、27例舌白斑和13例正常舌黏膜中MTUS1的表达,并对其表达水平进行统计学分析。定量反转录聚合酶链反应(RT-PCR)检测正常舌黏膜与TSCC中MTUS1亚型的表达水平并进行统计学分析。Kapalan-Meier法分析TSCC患者生存率,并统计分析MTUS1在TSCC中的表达与生存率之间的关系。SPSS 13.0统计软件分析数据。结果 在正常舌黏膜上皮中MTUS1主要表达于棘层细胞胞浆内,部分位于胞核。正常舌黏膜中MTUS1的表达水平明显高于舌白斑(t = 5.876,P=0.037)和TSCC(t = 7.638,P=0.000 83);舌白斑中MTUS1的表达明显高于TSCC,其差异有统计学意义(t = 5.281,P=0.0042)。MTUS1在高分化TSCC组织中的表达高于中分化和低分化者,但表达差异无统计学意义(F = 1.873,P=0.071)。定量RT-PCR检测显示,ATIP1、ATIP3a和ATIP3b是舌黏膜组织中MTUS1/ATIP的主要亚型;与正常舌黏膜相比,TSCC组织中MTUS1/ATIP亚型的表达明显降低,差异有统计学意义(t = 5.627,P=0.0153)。高表达MTUS1的TSCC患者生存率明显高于低表达者(F = 5.876,P=0.0286)。结论 MTUS1在TSCC的发生、发展中起着重要作用。  相似文献   

10.
目的探讨红细胞生成素(Epo)和红细胞生成素受体(EpoR)在舌鳞状细胞癌(TSCC)中的表达水平及其与微血管密度的关系.并结合临床病理资料评价其临床意义。方法采用免疫组织化学法检测具有完整临床病理资料的65例TSCC组织中Epo和EpoR表达情况.并同时检测其微血管密度.以50例癌旁组织作为对照。分析Epo和EpoR表达水平对TSCC患者预后的评估价值。结果TSCC组织中Epo和EpoR的表达高于癌旁组织(P〈0.05)。Epo的表达与患者的年龄、微血管的密度、肿瘤分期相关(P〈0.05)。EpoR的表达与微血管的密度相关(P〈0.05)。Kaplan—Meier生存分析显示Epo和EpoR阳性表达组患者总体生存率显著低于其阴性表达组。多因素Cox回归分析表明Ep0和EpoR表达水平是TSCC患者预后判断的重要因子(P〈0.05)。结论Epo和EpoR在TSCC发生发展及肿瘤微血管形成过程中起到重要作用.可能是评估TSCC患者预后的潜在标志物。  相似文献   

11.
A model describing the relationship between self-reported quality of restorative dentistry and dentist characteristics for 119 Montana general dentists is presented. The best predictors formed a significant model explaining 22% of the variance of the quality measure. Results are contrasted with a previous estimation of the model for 102 Washington general practitioners. Evidence for the external validity of the model is presented.  相似文献   

12.
The reduction of hydrazones is generally suggested to proceed through a reductive cleavage of the nitrogen–nitrogen bond followed by a reduction of the carbon–nitrogen bond. This sequence of reduction processes is here supported for fluorenone (V) and benzophenone (VI) hydrazones as well as by a comparison of the reduction of fluorenone and benzophenone hydrazonium ions (I,III) with corresponding imines (II,IV). Another proof of the presence of imines as intermediates is the splitting of four-electron waves of hydrazones V and VI and hydrazonium ions I and VIII into two waves at pH < 2. This has been interpreted as due to differences in slopes dE1/2/dpH and pKa-values of protonated hydrazine derivatives on one side and corresponding imines on the other. In this pH-range imines formed in reductions of VI and VIII are reduced in a single two-electron wave, those of I and V in two one-electron steps. Fluorenone imine (II) is sufficiently stable to allow recording of time-independent current–voltage curves between pH 6 and 11. In this pH-range the imine (II) is reduced in two one-electron steps. Benzophenone imine (IV) has been found stable between pH 4.6 and 12. At pH 4.6–8 the reduction of the imine IV takes place in a single two-electron step, at pH 8–12 in two one-electron steps. Final proof of the initial cleavage of the N–N bond is presented by comparison with the reduction of nitrones.  相似文献   

13.
The present paper on the design of clinical trials of periodontal therapy first addresses the issue of the etiology of periodontal disease. It is suggested that most if not all forms of destructive periodontal disease are caused by microorganisms and that there are different forms of disease with different microbial etiologies. The progressive nature of destructive periodontal disease is subsequently discussed and it is emphasized that, in a given patient, periodontal sites which show signs of inflammation and attachment loss may not over a period of several months and years show further sign of attachment loss. The present methods of assessing periodontal disease do not allow us to discriminate between potentially active and inactive sites in untreated patients. The significance and variability of indicators of periodontal disease such as bleeding on probing, probing pocket depth and probing attachment level measurements are discussed. The errors inherent in the various measurements are analyzed and suggestions are presented describing how alterations in any of the above parameters could be identified and presented in a clinical trial. Of concern for the statistical analysis of clinical data of periodontal disease is the definition of the "experimental unit". For a number of years, the "experimental unit" in periodontal trials was the patient. It is clear, however, that different sites within the same individual show different patterns of disease progression and lesion morphology and often respond differently to periodontal therapy. Statistical analyses must consequently be designed which recognize differences in site-to-site infection and lesion morphology within a common host. Until such analyses are available, the investigator should be wary of pooling data within the same individual, since such pooling may obscure meaningful alternatives which may take place in individual periodontal sites. Some goals of periodontal therapy are subsequently identified. 4 goals are discussed more in detail, namely: to establish conditions which will allow the patient to maintain a dentition without further breakdown of the periodontium; to reduce pocket depth to establish an anatomy in the dentogingival region which with proper maintainance care will prevent the re-establishment of the subgingival infection; to gain attachment as a result of treatment; to assess the effect of a certain chemotherapeutic agent on periodontal disease.  相似文献   

14.
目的研究正畸患者曲面体层片上的切牙影像失真发生情况,并分析其原因。 方法从中山大学附属口腔医院放射科影像数据库中选取500例正畸患者的曲面体层片和头影测量侧位片,所有曲面体层片均采用咬合杆投照,分别从切牙牙体影像放大、缩小、牙根变短、根尖模糊等评价指标分析上下颌切牙影像失真的发生情况,在头影测量侧位片上测量中切牙根尖-对颌切牙切缘的距离,探讨切牙影像失真发生的原因。采用SPSS 19.0统计软件对所得数据进行统计学检验。 结果500例患者中,切牙牙体影像正常者共417例,切牙牙体影像失真者共83例,影像失真发生率16.6%,其中切牙牙体影像放大17例、牙体影像缩小0例、牙根变短30例,牙根影像变短伴模糊36例。影像失真患者的根尖-切缘距离大于影像正常的患者,差异有统计学意义(F = 5 187.18,P = 0);影像失真患者的覆盖值大于影像正常的患者,差异有统计学意义(F>477,P = 0)。 结论严重牙颌面畸形如反 、深覆盖是导致曲面体层片的切牙影像失真的主要原因之一。  相似文献   

15.
颌骨动静脉畸形的栓塞治疗   总被引:9,自引:0,他引:9  
目的:总结直接穿刺结合经血管内介入栓塞治疗颌骨动静脉静脉畸形的经验。方法:收治凳骨动静脉畸形患者6例,均进行了介入栓塞治疗。采用的栓塞材料为附凝血棉纤毛的螺圈,聚乙烯醇泡沫微粒和二氰基丙烯酸对丁酯。数字减影颈动脉造影在PHILIPSV300下完成。结果6例颌骨动静脉畸形患者中4,例急性出血得到了快速、有效控制,1例慢性渗血的右下 骨动静脉畸形患者,介入栓塞治疗,拔除松动的右下凳第一磨牙,有效地控制了出血,另1例伴局部软组织搏动性膨隆的上凳骨动静脉畸形患者,介入治疗后膨隆的搏动性得到明显改善,栓塞治疗后分别随访3-24个月,均未发现有口腔内渗血或出血。随访的X线片上,病灶区可见新骨形成。结论:局部穿刺结合经血管内介入栓塞治疗颌骨动静畸形是一种安全、有效的治疗方法。  相似文献   

16.
ObjectiveLeukoplakia is the most common potentially malignant disorder preceding oral cancer. Chemiluminescence has been developed as an adjunct to conventional examination for the diagnosis of these potentially malignant disorders. This study was conducted to assess the efficacy of chemiluminescence in the diagnosis of leukoplakia and to compare the results with histopathological examination.Study designA total of 50 patients with leukoplakia were included from the outpatients attending the Department of Oral Medicine and Radiology, Dental Hospital, Bengaluru, Karnataka, India. These patients were subjected to conventional oral examination followed by chemiluminescent examination with Vizilite (Zila, Fort Collins, CO, USA) and biopsy for histopathological confirmation.ResultsThe sensitivity, specificity, positive predictive value, and negative predictive value of chemiluminescence were 93.75%, 55.56%, 78.95%, and 83.3%, respectively. The overall accuracy of chemiluminescence was 80%. A statistically significant association was observed between histopathology results and chemiluminescence results.ConclusionAlthough it is an easy, safe, minimal time consuming, and noninvasive technique, it has only adjunctive utility and it does not replace biopsy for the diagnosis of leukoplakia.  相似文献   

17.
目的测量正常青年Monson球面半径。方法选择60名(男30名,女30名)正常青年制取全口印模,应用立体摄影成像的原理与方法对Monson球面半径进行测量和统计学处理。结果Monson球面的半径平均为10.173 cm,大于理论值10.160 cm,差异有显著性(P<0.01);男、女性球面半径差异无显著性。结论本实验所得到的数据可作为全口义齿修复中记录颌位关系的一个参量。  相似文献   

18.
We report an electrochemical method to form a bilayer of dithiol. The cyclic voltammogram of the oxidative deposition of an aromatic dithiol on gold from an alkaline aqueous solution reveals two current peaks separated by more than 400 mV. The integrated charge of the oxidative current peak (B) at the most positive potential is twice that of the other oxidative current peak (A). These two oxidative current peaks were characterized by differential capacitance and electrochemical quartz crystal microbalance (EQCM) measurements. A decrease of the capacity by a factor of two, and an increase of the EQCM frequency change by a factor of two were observed when the potential was scanned from a value where only the first oxidative peak (A) is obtained, to a potential where both oxidative current peaks (A and B) are obtained. Infrared spectra show that the aromatic dithiols adsorb vertically at potentials corresponding to the current peak A and they become tilted for potentials corresponding to the current peak B. The simple relationships between the properties of the two oxidative current peaks are found to be compatible with a step-wise oxidative deposition of a bilayer of dithiol.  相似文献   

19.
口底癌34例临床分析   总被引:1,自引:0,他引:1  
目的探讨口底癌的临床特性、治疗方法及预后。方法对我院自1992—2002年住院治疗的34例口底癌患者进行回顾性分析。结果34例口底癌患者中,男28例(82.4%),女6例(17.6%),男女比为4.7∶1,平均发病年龄58岁。发病部位:前口底22例(64.7%),后口底12例(35.3%)。淋巴结转移率41.2%。单纯手术组、化疗加手术组、放疗加手术组、化疗加手术加放疗组的5年生存率分别为45.5%、60.0%、50.0%、62.5%。结论口底癌以中老年患者好发,男性居多。易发生淋巴结转移,综合疗法疗效较好。  相似文献   

20.
目的探讨复发舌前腺囊肿的病因和临床治疗方法。方法对20例复发舌前腺囊肿采取囊肿及同侧或双侧舌前腺完整摘除的手术方式进行治疗。结果 20例患者术后均I期愈合出院,术后随访6个月无复发。结论舌前腺有其自身的解剖生理特点,舌前腺囊肿不宜按一般黏液囊肿治疗原则进行,舌前腺囊肿及同侧或双侧舌前腺完整摘除是治疗舌前腺囊肿的可靠手段。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号